Top

Open Access 16-05-2024 | Breast Cancer | Commentary

Imaging evaluation of neoadjuvant breast cancer treatment: where do we stand?

Author: Marina Álvarez-Benito

Excerpt

Breast cancer has become the most commonly diagnosed malignancy among women worldwide. However, there have been improvements in survival from this disease due to screening programs and the use of more effective treatments [1]. …

DynaMed (2024). Breast Cancer in Women. EBSCO Information Services. Accessed 4 March de 2024. https://www.dynamed.com/condition/breast-cancer-in-women

Houssami N, Macaskill P, von Minckwitz G, Marinovich ML, Mamounas E (2012) Metaanalysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy. Eur J Cancer 48:3342–3354CrossRefPubMed

American College of Radiology ACR Appropriateness Criteria® Monitoring Response to Neoadjuvant Systemic Therapy for Breast Cancer, revised 2022. https://acsearch.acr.org/docs/3099208/Narrative/, accessed in March 15, 2024

Mann RM, Balleyguier C, Batlzer PA et al (2015) Breast MRI: EUSOBI recommendations for women’s information. Eur Radiol 25:3669–3678. https://doi.org/10.1007/s00330-015-3807-zCrossRefPubMedPubMedCentral

Fowler AM, Mankoff DA, Joe BN (2017) Imaging neoadjuvant therapy response in breast cancer. Radiology 285:358–375CrossRefPubMed

Goulam-Houssein S, Ye XY, Fleming R et al (2024) Evaluating persistent T1-weighted lesions without concurrent abnormal enhancement on breast MRI in neoadjuvant chemotherapy patients: implications for complete pathological response. Eur Radiol https://doi.org/10.1007/s00330-024-10695-7

Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247CrossRefPubMed

Fisher B, Bryant J, Wolmark N et al (1998) Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16:2672–2685CrossRefPubMed

Rauch GM, Adrada BE, Kuerer HM, van la Parra RFD, Leung JWT, Yang WT (2017) Multimodality imaging for evaluating response to neoadjuvant chemotherapy in breast cancer. AJR Am J Roentgenol 208:290–299CrossRefPubMed

10.

Gu J, Tong T, Xu D et al (2023) Deep learning radiomics of ultrasonography for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: a multicenter study. Cancer 129:356–366. https://doi.org/10.1002/cncr.34540CrossRefPubMed

Title: Imaging evaluation of neoadjuvant breast cancer treatment: where do we stand?
Author: Marina Álvarez-Benito
Publication date: 16-05-2024
Publisher: Springer Berlin Heidelberg
Keywords: Breast Cancer
Breast Cancer
Magnetic Resonance Imaging
Magnetic Resonance Imaging
Breast MRI
Published in: European Radiology
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-024-10799-0

ERS Congress 2024

Springer Medicine

Imaging evaluation of neoadjuvant breast cancer treatment: where do we stand?

Excerpt

ERS Congress 2024

Springer Medicine

Excerpt

Please log in to get access to this content